The prevalence of smoking among Croatian hospitalized coronary heart disease patients [Prevalencija pušenja u hospitaliziranih bolesnika u Hrvatskoj] by Vražić, Hrvoje et al.
Coll. Antropol. 36 (2012) Suppl. 1: 229–233
Original scientific paper
The Prevalence of Smoking among Croatian
Hospitalized Coronary Heart Disease Patients
Hrvoje Vra`i}1, Jozica [iki}1,2, Tomo Lucijani}1,3, Milan Milo{evi}3,4, Katarina Bori}3, Mario Udovi~i}1,
Jasna Cmre~njak5, Inge Heim6, Mirjana Jembrek Gostovi}6 and Mijo Bergovec1,3
1 University of Zagreb, Dubrava University Hospital, Department of Internal Medicine, Division of Cardiology, Zagreb, Croatia
2 University of Zagreb, Sveti Duh University Hospital, Department of Internal Medicine, Division of Cardiology, Zagreb, Croatia
3 University of Zagreb, School of Medicine, Zagreb, Croatia
4 University of Zagreb, School of Medicine, »Andrija [tampar« School of Public Health, Zagreb, Croatia
5 ^akovec General Hospital, Department of Internal Medicine, Division of Cardiology, ^akovec, Croatia
6 Institute for Cardiovascular Prevention and Rehabilitation, Zagreb, Croatia
A B S T R A C T
The aim of this paper was to investigate the prevalence of smoking using selected anthropometric variables in a sam-
ple of hospitalized coronary heart disease (CHD) patients in Croatia (N=1,298). A total of 444 subjects (34.6%) were
non-smokers, 548 (42.6%) were smokers and 293 (22.8%) were ex-smokers. Men, on average, smoked more cigarettes per
day than women (22.62 vs. 19.84 cigarettes, p<0.001) and they also had bigger index »pack-years« than women (36.96
vs. 33.91, p=0.024). Men were more often smokers and ex-smokers than women (47.4% vs. 30.8% for smokers and 25.0%
vs. 22.8% for ex-smokers, p<0.001). In this study a high prevalence of smoking was found among CHD patients in
Croatia. Unless it is decreased, it can be expected that CHD patients in Croatia will continue to experience adverse effects
more often than other CHD patients in the rest of Europe.
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Introduction
Research, conducted amongst the general population,
has shown that smoking is not only an independent risk
factor for the occurrence of coronary heart disease (CHD),
cerebrovascular disease and atherosclerotic disease in
general1, but that it also increases total and cardiovascu-
lar mortality2–5. Smoking doubles the risk of cardiovascu-
lar death and it is estimated that approximately 30–40%
of all deaths from CHD are the result of smoking. It is
considered to be the leading cause of premature death in
Europe which can efficiently be prevented6.
It has been shown that smoking is also an independ-
ent risk factor for occurrence of type 2 diabetes mellitus7,
which also accelerates progression of atherosclerosis and
nephropathy8–10. Incidence of myocardial infarction is in-
creased sixfold in women and threefold in men who
smoke at least 20 cigarettes a day in comparison to peo-
ple who have never smoked11,12. In the INTERHEART
study (A global study of risk factors in acute myocardial
infarction), which was conducted in 52 countries, it has
been shown that smoking was responsible for 36% of at-
tributive risk for occurrence of first myocardial infarc-
tion13. Patients with established cardiovascular disease
(CVD) who continue to smoke have an increased rein-
farction risk as well as risk from death, which also in-
cludes sudden cardiac death14,15. On the other hand, it
has also been shown that quitting smoking has a favour-
able effect on the prognosis of coronary disease16. Al-
though smoking status before aortocoronary bypass pro-
cedure does not have an effect on postoperative survival,
it has been shown that smokers who continue to smoke
after this procedure have an increased risk of total mor-
tality (RR 1.68), cardiac death (RR 1.75) and more fre-
quently need repeated operative procedures (RR 1.41) in
comparison with those who stopped smoking for at least
a year17. Similar results have been obtained in a study
which followed patients after percutaneous coronary in-
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tervention and angioplasty. It was shown that smokers
who continue to smoke have a higher relative risk of
death (RR 1.76) and the occurrence of Q infarction (RR
2.08) in comparison with non-smokers, while they also
have a higher risk of total and cardiac mortality (RR 1.44
and 1.49) in comparison with those that have stopped
smoking18.
The advantages of stopping smoking in patients with
CHD have been shown in a meta-analysis performed on
12,603 smokers who had myocardial infarction, aortoco-
ronary bypass, angioplasty or known CHD. The relative
risk of mortality in those that have stopped smoking in
comparison with those who continue to smoke was 0.6419.
Another cohort study performed on 2,619 patients who
had a first myocardial infarction and were discharged
from hospital has shown that in those who permanently
quit smoking the risk had been decreasing, continually
and significantly over time from the point of quitting
smoking (RR 1.62 in period 0 to <6 months; RR 1.60 in
period 6 to <18 months; RR 1.48 in period 18 to <36
months and RR 1.02 in period >=36 months)20.
Smoking has also received a lot of attention in Croatia,
both in general and specific populations. First reported
data in literature, which is more than 30 years ago,
showed that men smoked more frequently than women21.
Data from Croatian Adult Health Survey (CAHS) from
2003 showed that 27.4% of Croatia’s adult population
smoked on a daily basis and that men were more often
smokers than women22,23. Some authors propose that
smokers should be divided into two groups – smokers
who smoke up to 20 cigarettes per day and those who
smoke more than 20 cigarettes per day and who can be
considered »heavy smokers«24. According to this crite-
rion, data from CAHS showed that men in Croatia were
more often »heavy smokers« than women in all age
groups, while most of women who are smokers could be
classified as »light smokers« – meaning that they smoke
up to 20 cigarettes per day25. There has also been some
research performed in some specific populations. Of spe-
cial interest is the data acquired from a study on health
professionals and medical students in Croatia which show-
ed that the frequency of smoking in this population is not
favourable et all.26,27.
Materials and Methods
Our survey included 1,298 patients hospitalized be-
tween October 1st 2007 and January 7th 2010 for acute or
chronic CHD in various hospitals in Croatia: Dubrava
University Hospital (Zagreb), Sveti Duh University Hos-
pital (Zagreb), Bjelovar General Hospital, ^akovec General
Hospital, Karlovac General Hospital, Koprivnica General
Hospital, Slavonski Brod General Hospital, Vara`din Ge-
neral Hospital, Rijeka University Hospital Centre, Pula
General Hospital, Split University Hospital Centre, Du-
brovnik General Hospital and Zadar General Hospital.
A special questionnaire was produced for this study
which allowed recording of required data. The question-
naire was finalised after a series of consultations with ex-
perts and literature and it was compiled using the model
of large clinical trials conducted in Europe and Croatia
[INTERHEART13, EUROASPIRE (European action on
secondary prevention by intervention to reduce events)
I28 and II29, EH-UH (Epidemiology of hypertension in
Croatia)30, TASPIC-CRO (Treatment and secondary pre-
vention of ischemic coronary events in Croatia)31]. This
allowed the investigators to be able to efficiently com-
pare results. Most of the questions had multiple answers
offered in advance to achieve greater accuracy. Data was
collected on patient history (personal and family his-
tory), age, sex and information on cardiovascular risk
factors and discharge diagnoses. A physical examination
was performed and its findings were recorded. The spe-
cial focus in the questionnaire was on smoking.
Smokers were defined as persons who have smoked
different forms of tobacco in the period of 12 months be-
fore the interview; this also includes those that have
stopped smoking in those 12 months. Ex-smokers were
defined as persons that have stopped smoking more than
12 months ago at the time of interview. In the question-
naire were recorded the forms of tobacco which were used
(cigarettes, cigars, pipes, tobacco for chewing), smoking
status (never, currently, stopped smoking), duration of
smoking (age when a person began to smoke and when
they stopped smoking) and number of cigarettes smoked
per day. According to the data recorded in the question-
naire it was possible to calculate the index »pack-years«
by multiplying the number of smoked cigarettes (in num-
ber of packs, where one pack contains 20 cigarettes) with
duration of smoking (in years). This index is well ac-
cepted in literature as a measure of one’s lifetime burden
of smoking.
Data was collected by physicians or trained personnel
(nurse), coded and entered into the electronic file. Confi-
dentiality of data was ensured in accordance with current
applicable codes, declarations and other provisions. The
results are shown in tables, and for quantitative variables
descriptive statistics were prepared with appropriate mea-
sures of central tendency and variability (mean, standard
deviation, medians, associated interquartile ranges). Nor-
mal distribution of quantitative variables was tested by
the Kolmogorov-Smirnov test, and then appropriate pa-
rametric (t-test for independent samples and analysis of
variance – ANOVA) or nonparametric tests (Mann-Whit-
ney U test, Kruskal-Wallis test) were used. The c2 test
was also used.
Statistically significant results were considered those
with p values <0.05. Statistical analysis was made us-
ing the software PASW version 17.02 (Chicago Inc., IL,
www.spss.com).
Results
In this article we analysed only data on tobacco con-
sumption in the form of cigarettes, as other forms of to-
bacco consumption were reported in negligible frequencies.
A total of 444 subjects (34.6%) were non-smokers, 548
(42.6%) were smokers and 293 (22.8%) were ex-smokers.
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It was also possible to divide subjects into two groups
in relation to their smoking status: in the first group
there were subjects that have never smoked (444 sub-
jects, 34.6%) and in the second group there were subjects
who have experienced the harmful effects of tobacco – as
it included those who were either ex-smokers or current
smokers (841 subjects, 65.4%).
As shown in Table 1, there were no statistically signif-
icant differences between men and women in the dura-
tion of smoking. There was, however, a statistically sig-
nificant difference concerning the average daily number
of smoked cigarettes and index »pack-years«. Men, on av-
erage, smoked more cigarettes per day than women (22.62
vs. 19.84 cigarettes, p<0.001, Mann Whitney U test) and
they also had bigger index »pack-years« than women
(36.96 vs. 33.91, p=0.024, Mann Whitney U test).
Comparison of subject’s smoking status (3 groups:
never-smokers, smokers and ex-smokers) by sex is shown
in Table 2. Men were more often smokers and ex-smok-
ers than women (47.4% vs. 30.8% for smokers and 25.0%
vs. 22.8% for ex-smokers, p<0.001, c2-test). When the
subject’s smoking status was divided only into 2 groups
(Table 3, group 1: never smokers, groups 2: smokers and
ex-smokers) men were statistically significantly more of-
ten in the group of smokers and ex-smokers than women
(72.5% vs. 48.1%, p<0.001, c2-test).
Discussion
This article investigates the prevalences of smoking
among CHD patients in Croatia. Smoking is a behav-
ioural risk factor, thus its occurrence is completely de-
pendent on one’s behaviour32.
Tobacco use, most often in the form of smoking, has
been shown to have deleterious effects on one’s health1–5.
Smoking has been shown to double the risk of death from
CVD and it has been estimated that up to 40% of all
deaths from CHD are a direct result of smoking. There-
fore it is not surprising that smoking is the leading cause
of premature death in Europe which can completely and
effectively be prevented6. An illustrative example on the
deleterious effects of smoking are the data from a study
that showed that the incidence of myocardial infarction
is increased sixfold in women and threefold in men who
smoke at least 20 cigarettes a day in comparison with
persons that have never smoked11,12.
Results were compared with two other relevant stud-
ies performed on CHD patients in Croatia within the last
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TABLE 1
SMOKING STATUS AMONG SUBJECTS BY SEX
Sex N Mean SD Min.
Percentiles
Max. p
25. 50. (Median) 75.
Duration of
smoking (years)
Men 658 32.27 13.35 1.00 23.00 33.00 41.00 68.00
0.196
Women 178 34.08 13.73 4.00 25.00 33.00 44.00 71.00
Average number of
cigarettes per day
Men 663 22.62 9.33 1.00 20.00 20.00 20.00 100.00
<0.001
Women 178 19.84 8.40 1.00 20.00 20.00 20.00 60.00
Index »pack-years«
Men 658 36.96 23.37 0.80 23.00 33.00 45.00 275.00
0.024
Women 178 33.91 23.40 2.60 20.00 30.00 42.00 162.00
N – number, SD – standard deviation, Min. – minimum, Max. – maximum
TABLE 2
SMOKING STATUS (3 GROUPS) BY SEX
Sex
Smoking status (3 groups)
Total
Never-smokers Smokers Ex-smokers (>12 months)
Male 252 (27.5%) 434 (47.4%) 229 (25.0%) 915 (100.0%)
Female 192 (51.9%) 114 (30.8%) 64 (17.3%) 370 (100.0%)
Total 444 (34.6%) 548 (42.6%) 293 (22.8%) 1285 (100.0%)
c2=69.185; df=2; p<0.001
c2 test was used, p<0.05 is considered statistically significant
% – percent, df – degrees of freedom
TABLE 3
SMOKING STATUS (2 GROUPS) BY SEX
Sex
Smoking status (2 groups)
Total
Never-smokers Smokers*
Male 252 (27.5%) 663 (72.5%) 915 (100.0%)
Female 192 (51.9%) 178 (48.1%) 370 (100.0%)
Total 444 (34.6%) 841 (65.4%) 1285 (100.0%)
c2=69.084; df=1; p<0.001
c2 test was used, p<0.05 is considered statistically significant
% – percent, df – degrees of freedom
* Smokers includes both current smokers and persons that have
quit smoking more than 12 months before interview
decade. The first was an international study – European
action on secondary prevention by intervention to reduce
events (EUROASPIRE) III study, performed in 22 Euro-
pean countries (one of which was Croatia, allowing com-
parison of data) in 200633. The second study was per-
formed in 2002 and 2003 on hospitalized CHD patients in
Croatia – Treatment and secondary prevention of ische-
mic coronary events in Croatia (TASPIC-CRO) V study31.
In our study 548 patients (42.6%) were smokers. This
high prevalence of smokers shows that smoking in a pop-
ulation of CHD patients is similar to that of the general
population23 and that among CHD patients in Croatia
smoking is higher than the European average (17%)33
This prevalence is on the rise in Croatia (TASPIC-CRO V
study reported smoking in 35% of CHD patients in Croa-
tia)31. If those that have stopped smoking previously for
more than 12 months are added to this number (who
have also experienced deleterious effects of smoking), we
can say that 841 subjects (65.4%) have experienced those
harmful effects of smoking, which is indicative for the
important role of smoking as a cardiovascular risk factor
in Croatia. Bearing in mind the type of population sur-
veyed (CHD patients) such high prevalence is not so sur-
prising as the connection between smoking and CHD is
well known1,11,12.
Furthermore, there have been statistically significant
differences in smoking between sexes – men smoke more
cigarettes per day than women (Table 1, 22.62 cigarettes
per day in men vs. 19.84 cigarettes per day in women,
p<0.001), and therefore men have higher index »pack-
-years« than women (Table 1, 36.96 in men vs. 33.91 in
women, p=0.024). Men were also statistically signifi-
cantly more likely to be smokers than women (Table 2,
47.4% of men vs. 30.8% of women, p<0.001). It is impor-
tant to note that such pattern of differences between
sexes is also present in the general population, as shown
in CAHS from 200323,25. EUROASPIRE III study has also
shown that male CHD patients are more frequently
smokers than female CHD patients33.
Messages from this study become clearer when one
remembers that it has been reported in literature that
patients with established CVD who continue to smoke
have an increased risk of reinfarction and an increased risk
of death, which also includes sudden cardiac death14,15.
Unless this high prevalence of smoking is decreased, it
can be expected that CHD patients in Croatia will con-
tinue to experience the above mentioned adverse effects
more often than other CHD patients in the rest of Eu-
rope. It is reassuring to some extent that it has also been
shown in literature that stopping smoking has been
proven to have beneficial influence on the prognosis of
CHD16. This should serve as a strong stimulus to further
concentrate our efforts to reduce smoking not just in the
population of CHD patients, but also in the general popu-
lation through more effective initiatives and interven-
tions targeting primarily changes of lifestyle and bad
habits.
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PREVALENCIJA PU[ENJA U HOSPITALIZIRANIH KORONARNIH BOLESNIKA U HRVATSKOJ
S A @ E T A K
Cilj ovog rada bio je pokazati prevalenciju pu{enja uz izabrane antropometrijske varijable na uzorku bolesnika hos-
pitaliziranih zbog koronarne bolesti u Republici Hrvatskoj (N=1.298). Nikada nije pu{ilo 444 ispitanika (34,6%), 548
(42,6%) ispitanika bili su pu{a~i i 293 (22.8%) ispitanika bili su biv{i pu{a~i. Mu{karci su, u prosjeku, pu{ili vi{e cigareta
dnevno od `ena (22,62 prema 19,84 cigareta, p<0,001) i tako|er su imali ve}i indeks »pack-years« od `ena (36,96 prema
33,91, p=0,024). Mu{karci su ~e{}e bili pu{a~i i biv{i pu{a~i nego `ene (47,4% prema 30,8% za pu{a~e i 25,0% prema
22,8% za biv{e pu{a~e, p<0,001). U ovom istra`ivanju prona|ena je visoka prevalencija pu{enja kod bolesnika hospitali-
ziranih zbog koronarne bolesti srca u Hrvatskoj. Ukoliko se ona ne smanji, mo`e se o~ekivati kako }e ti bolesnici u bu-
du}nosti ~e{}e do`ivljavati {tetne doga|aje nego koronarni bolesnici u ostatku Europe.
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